Fusion Antibodies plc Lands Contract for Antibody Research Project

MT Newswires · 2d ago
04:50 AM EDT, 10/22/2026 (MT Newswires) -- Fusion Antibodies plc (FAB.L) won a new contract for an antibody and cryogenic electron microscopy project of an existing US pharmaceutical client. The British contract research organization said Thursday that the project covers the transient gene expression of the client's study. The new contract is under a previously established master services agreement. Project completion is expected in 2026, with potential revenue of more than 85,000 pounds sterling.